Enterprise Value
0.00
Cash
123.6M
Avg Qtr Burn
N/A
Short % of Float
1.14%
Insider Ownership
2.23%
Institutional Own.
62.64%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MGTA-145 + plerixafor Details Sickle cell disease | Failed Discontinued | |
MGTA-456 Details Leukemia, Cancer | Failed Discontinued |